BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, August 3, 2026
Home » Keywords » targets

Items Tagged with 'targets'

ARTICLES

Illustration of dopamine signaling in the brain
Neurology/psychiatric

New schizophrenia targets challenge trial design

July 28, 2026
By Mar de Miguel
No Comments
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated failures of some late-stage programs may reflect not only the complexity of the disease, but also the need to better identify the patients most likely to benefit from each approach.
Read More
Ovarian cancer illustration
Immuno-oncology

CD98hc as promising target for ADC therapy in ovarian cancer

July 20, 2026
No Comments
In a recently published study, researchers from the Institute of Biomedical Research of Salamanca and collaborators investigated the potential of CD98hc as a novel antibody-drug conjugate (ADC) target in ovarian cancer. CD98hc, encoded by the SLC3A2 gene, is a transmembrane glycoprotein involved in amino acid transport, cell adhesion and signal transduction, among other biological activities.
Read More
Lungs
Cardiovascular

SMC4 blockade ameliorates preclinical pulmonary arterial hypertension

July 16, 2026
No Comments
Pulmonary arterial hypertension (PAH) is a fatal condition characterized by abnormal vascular remodeling from excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs). Recent evidence has suggested that structural maintenance of chromosomes 4 (SMC4) is upregulated in pulmonary tissue from patients with PAH and may be a potential target for therapy, since it has been tied to modulating pathological cell proliferation.
Read More
Doctor holding illustration of cross section of skin
Dermatologic

TXNRD1 links keratinocyte hyperproliferation and inflammation in psoriasis, emerging as a target

July 10, 2026
No Comments
Thioredoxin reductase 1 (TXNRD1) is a key component of the thioredoxin antioxidant system that helps maintain cellular redox homeostasis and regulates critical cellular processes such as proliferation, apoptosis and immune responses. A team of researchers at Central South University systematically investigated TXNRD1 expression and function in psoriatic keratinocytes using gene expression datasets, clinical samples and in vitro and in vivo models.
Read More
Lungs wireframe illustration
Respiratory

USP43 targeting protects against acute lung injury

July 9, 2026
No Comments
Acute lung injury (ALI) is an inflammatory pulmonary disease mainly caused by infection. It can progress to the life-threatening condition acute respiratory distress syndrome (ARDS). ALI/ARDS account for a high mortality rate of about 40%. Elucidating the mechanisms behind ALI/ARDS is crucial for developing new therapeutics.
Read More
Myelin sheath and neurons in the brain
Neurology/psychiatric

GDE4 blockade promotes remyelination, study finds

July 7, 2026
No Comments
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the CNS are oligodendrocytes (OLs), which derive from oligodendrocyte precursor cells (OPCs).
Read More
Cancer cell destruction by nanoparticles
Cancer

LAMP2A modulation regulates ovarian cancer response to platinum

July 6, 2026
No Comments
Ovarian clear-cell carcinoma is a cancer characterized by inherent resistance to platinum-based therapies and lacks an effective targeted therapeutic approach. On the other hand, chaperone-mediated autophagy is a lysosomal degradation mechanism to stabilize cellular homeostasis during stressful scenarios, but its role in modulating platinum response in ovarian cancer is not well understood.
Read More
Illustration of tumor in the liver
Cancer

SET1B blockade as an approach in hepatocellular carcinoma

July 6, 2026
No Comments
Researchers in Korea have investigated the interaction of SET-domain containing 1B (SET1B) with other proteins in vitro, as well as the impact of SET1B depletion in hepatocellular carcinoma cell lines.
Read More
Human heart within crosshairs
Cardiovascular

Targeting FAM3D as a strategy against atherosclerosis

July 3, 2026
No Comments
FAM3D is a protein mainly expressed in the gastrointestinal tract, but also detectable in vascular endothelial cells. It is known to worsen intestinal inflammation by recruiting neutrophils, but its role in atherosclerosis is not well understood.
Read More
Illustration of a tumor
Cancer

CLDN1 targeting suppresses CCA tumor growth

July 2, 2026
No Comments
Analyzing different databases, researchers found that CLDN1 was the most highly expressed claudin in tissue samples from patients with cholangiocarcinoma (CCA), both in intrahepatic and extrahepatic CCA subtypes, compared with nontumoral bile duct samples.
Read More
More Articles Tagged with 'targets'

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 31, 2026.
  • HIV virus

    AIDS 2026: New targets for metabolic dysfunction despite ART

    BioWorld
    Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
  • Jingxin discloses new muscarinic and sigma receptor agonists

    BioWorld Science
    Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
  • Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

    BioWorld Science
    Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
  • Silhouette illustration of DNA gene editing

    Death in Chinese gene-editing trial exposes ethical fault lines

    BioWorld
    The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing